Go to content

Ronidazole-d3, *analitical standard, pharma clinical testing, mg.100, ACS, cas 1015855-87-4 - https://www.eurchem.net

Skip menu
bio-chemical engineering for innovative research
Skip menu
technical file
:
C.O.A.
product name
synonyms    
product origin
purity grade
use
applications
product code
C.A.S. number
MDL
linear formula
molecular weight
melting point
SMILE
InChl
InChl key
storage & sensitivity
assay
appearance (color)
form
description
x
x
disclaimer
x
packaging/transport
standardization
:
:
:
:
:
:
:
:
:
:
:
:
:
:
:
:
:
:
:
:
:
:
:
:
:
:

Ronidazole-d3, * analytical standard,  ACS - sterilized- sterilized
2-(Carbamoyloxymethyl)-1-methyl-d3-5-nitro-imidazole ;
100% made in European Union *(according to USP, Echa-Reach) ;
>99.99% (raw matter, ultra-pure, selected) ;
Tech. / Lab. / synthesis / Pharmaceutical / analytical standard ;
pharmaceutical *clinical testing ;
ES712A
1015855-87-4
MFCD09265285
C6D3H5N4O4
203.17
166 °C to 168 °C
[2H]C([2H])([2H])n1c(COC(N)=O)ncc1[N+]([O-])=O ;
1S/C6H8N4O4/c1-9-4(3-14-6(7)11)8-2-5(9)10(12)13/h2H,3H2,1H3,(H2,7,11)/i1D3 ;
PQFRTXSWDXZRRS-FIBGUPNXSA-N ;
ambient temperatures
>99.99%  <101,00%
white
powder
Ronidazole-d3 may be used internal standard in the determination of avermectins, benzimidazoles and nitroimidazoles residues in bovine muscle tissue using ultra-high performance liquid chromatography coupled with mass spectrometry (UHPLC/MS-MS).
1) This product is for research use only, is not to be used for therapeutic; not intended for animal or human or
2) diagnostic or therapeutic use , and cannot be sold to patients ..
Special for chemical transport (according to IATA / ADR / ECHA-REACH rules / int.l laws) .
According to U.S. / E.U. Pharmacopoeia, Echa-Reach, UNI EN ISO 14001, G.M.P., M.S.D.S., etc...
*
possible additional
 discount for large
quantity orders


     pharmaceutical  and chemicals Division
Bangarten, 21/15 - Vaduz (Liechtenstein) LI9490
exclusive dealer for Europe :
Eurchem
copyright ©®™ 2026





_________________________________________________________________________________________________________________________________________________________________


Back to content